Scientists uncovered a surprising four-layer structure hidden inside the hippocampal CA1 region, one of the brain’s major centers for memory, navigation, and emotion. Using advanced RNA imaging ...

In every way, Taylor Hyma, 18, was a “normal teen.” She went to school, worked, hung out with friends, and took care of herself. Then suddenly, her life began to ...

Exclusive AES 2025 coverage on medication-resistant epilepsy, wearable EEG technology for seizure detection, treatment for refractory status epilepticus, and more.

The latest announcement is out from Xenon ( (XENE) ).

Post-hoc analysis of RAP-219 Phase 2a data showed early onset of action and consistency of median response over the entire ...

Sarah Trudelle is raising funds to support researchers offering valuable information on her daughter’s medical ketogenic diet ...

To date, ETX101 has shown a favorable safety profile and has been well-tolerated across all four dose levels with no treatment-related serious adverse events (n=19). The most common treatment-related ...

Relutrigine targets patients suffering from severe, genetic epilepsy syndromes. ・To date, no approved therapy specifically ...

The report from the Australian Institute of Health and Welfare (AIHW) found that around 2.2 million Australians were living with a long-term neurological condition in 2022, representing 8.7 percent of ...

Nihon Kohden, a global leader in neurodiagnostic technology, will showcase its integrated EEG portfolio at the American ...

Today, NeuroVice announced that PATI is now commercially available, marking a breakthrough moment for millions of patients living with focal and grand-mal seizures. The company will debut the ...

To help scientists learn more about epilepsy, Alan Song has used a Summer Undergraduate Research Fellowship to build a new software package that displays brain activity data for epilepsy in a ...